MoneyWorks4Me

Marksans Pharma - Quaterly Results

10 Nov 2021 Evaluate
The revenue for the September 2021 quarter is pegged at Rs. 1688.53 millions, about 22.76% up against Rs. 1375.52 millions recorded during the year-ago period.Net profit stood at Rs. 275.97  millions  compared to Rs. 235.34 millions in the corresponding previous quarter,high by 17.26%.Operating profit for the quarter ended September 2021 rose to 425.27 millions as compared to 360.04 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1688.53 1375.52 22.76 3160.74 2935.11 7.69 5995.48 4334.15 38.33
Other Income 85.98 129.57 -33.64 225.38 130.06 73.29 311.56 1.73 17909.25
PBIDT 425.27 360.04 18.12 815.64 650.56 25.38 1448.68 716.63 102.15
Interest 12.02 13.21 -9.01 18.32 21.09 -13.13 53.45 72.92 -26.70
PBDT 413.25 346.83 19.15 797.32 629.47 26.67 1395.23 643.71 116.75
Depreciation 43.04 36.71 17.24 85.33 70.14 21.66 151.93 116.44 30.48
PBT 370.21 310.12 19.38 711.99 559.33 27.29 1243.30 527.27 135.80
TAX 94.24 74.78 26.02 146.96 103.43 42.09 259.49 148.24 75.05
Deferred Tax 18.60 11.20 66.07 15.08 -22.87 -165.94 -22.39 36.77 -160.89
PAT 275.97 235.34 17.26 565.03 455.90 23.94 983.81 379.03 159.56
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 25.19 26.17 -3.78 25.81 22.16 16.42 24.16 16.53 46.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..